These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3336884)
21. Fluoro-substituted N-nitrosamines. 8. N-Nitrosodibutylamine and omega-fluorinated analogues: in vivo metabolism in relation to the induction of urinary bladder cancer in the rat. Gottfried-Anacker J; Preussmann R; Eisenbrand G; Janzowski C Carcinogenesis; 1985 Nov; 6(11):1559-64. PubMed ID: 4053275 [TBL] [Abstract][Full Text] [Related]
22. Differences in susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis. Murai T; Mori Y; Tatematsu K; Koide A; Hagiwara A; Makino S; Mori S; Wanibuchi H; Fukushima S Cancer Sci; 2005 Oct; 96(10):637-44. PubMed ID: 16232194 [TBL] [Abstract][Full Text] [Related]
23. Effects of butylated hydroxyanisole on the tumorigenicity and metabolism of N-nitrosodimethylamine and N-nitrosopyrrolidine in A/J mice. Chung FL; Wang M; Carmella SG; Hecht SS Cancer Res; 1986 Jan; 46(1):165-8. PubMed ID: 3940189 [TBL] [Abstract][Full Text] [Related]
24. Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4-hydroxybutyl)amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder. Airoldi L; Magagnotti C; Bonfanti M; Fanelli R Carcinogenesis; 1990 Aug; 11(8):1437-40. PubMed ID: 2387032 [TBL] [Abstract][Full Text] [Related]
25. Mutagenicity of N-butyl-N-(4-hydroxybutyl)nitrosamine, a bladder carcinogen, and related compounds. Nagao M; Suzuki E; Yasuo K; Yahagi T; Seino Y Cancer Res; 1977 Feb; 37(2):399-407. PubMed ID: 318920 [TBL] [Abstract][Full Text] [Related]
26. Butylated hydroxyanisole-induced alterations in cell kinetic parameters in rat forestomach in relation to its oxidative cytochrome P-450-mediated metabolism. Verhagen H; Furnée C; Schutte B; Hermans RJ; Bosman FT; Blijham GH; ten Hoor F; Henderson PT; Kleinjans JC Carcinogenesis; 1989 Oct; 10(10):1947-51. PubMed ID: 2791210 [TBL] [Abstract][Full Text] [Related]
27. Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes. Levine WG Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):113-20. PubMed ID: 6438741 [TBL] [Abstract][Full Text] [Related]
28. Effects of butylated hydroxyanisole pretreatment on low dose N-methyl-N'-nitro-N-nitrosoguanidine- or N,N-dibutylnitrosamine-induced rat forestomach or esophageal carcinogenesis. Hirose M; Uwagawa S; Ozaki K; Takaba K; Ito N Carcinogenesis; 1991 Oct; 12(10):1773-6. PubMed ID: 1934256 [TBL] [Abstract][Full Text] [Related]
29. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats. Imaida K; Fukushima S; Inoue K; Masui T; Hirose M; Ito N Cancer Lett; 1988 Dec; 43(3):167-72. PubMed ID: 3203335 [TBL] [Abstract][Full Text] [Related]
31. Oxidation of N-butyl-N-(3-formylpropyl)nitrosamine to N-butyl-N-(3-carboxypropyl)nitrosamine in rat liver and inhibition by disulfiram. Irving CC Carcinogenesis; 1988 Nov; 9(11):2109-12. PubMed ID: 3180345 [TBL] [Abstract][Full Text] [Related]
32. Effect of butylated hydroxyanisole on electron transport in rat liver mitochondria. Ferreira J Biochem Pharmacol; 1990 Aug; 40(4):677-84. PubMed ID: 2143654 [TBL] [Abstract][Full Text] [Related]
33. Metabolic fate of N,N-dibutylnitrosamine in the rat. Suzuki E; Okada M Gan; 1980 Dec; 71(6):863-70. PubMed ID: 7274631 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatic microsomal cytochrome P-450 dependent monooxygenation activity by the antioxidant 3-tert-butyl-4-hydroxyanisole. Rodrigues AD; Fernandez D; Nosarzewski MA; Pierce WM; Prough RA Chem Res Toxicol; 1991; 4(3):281-9. PubMed ID: 1912310 [TBL] [Abstract][Full Text] [Related]
35. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse. Monroe DH; Eaton DL Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723 [TBL] [Abstract][Full Text] [Related]
36. Induction of tumours by administration of N-dibutylnitrosamine and derivatives to infant mice. Fujii K; Odashima S; Okada M Br J Cancer; 1977 May; 35(5):610-4. PubMed ID: 861148 [TBL] [Abstract][Full Text] [Related]
37. Cytotoxicity of butylated hydroxyanisole and butylated hydroxytoluene in isolated rat hepatocytes. Thompson D; Moldéus P Biochem Pharmacol; 1988 Jun; 37(11):2201-7. PubMed ID: 3377819 [TBL] [Abstract][Full Text] [Related]
38. Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia. Shibata MA; Shirai T; Asakawa E; Hirose M; Fukushima S Int J Cancer; 1993 Mar; 53(5):819-23. PubMed ID: 8449607 [TBL] [Abstract][Full Text] [Related]
39. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat. Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665 [TBL] [Abstract][Full Text] [Related]
40. On the mechanisms of 3-tert-butyl-4-hydroxyanisole- and its metabolites-induced cytotoxicities in isolated rat hepatocytes. Nakagawa Y; Nakajima K; Moore G; Moldéus P Eur J Pharmacol; 1994 Aug; 270(4):341-8. PubMed ID: 7805783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]